Technical Analysis for MCRB - Seres Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.82 0.26% 0.00
MCRB closed up 0.26 percent on Friday, November 1, 2024, on 56 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Earnings Movers Other 0.00%
Inside Day Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Gapped Down Weakness 0.00%
Crossed Above 20 DMA Bullish 0.26%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 17 hours ago
Possible Inside Day about 17 hours ago
Reversed from Down about 19 hours ago
Gap Down Closed about 21 hours ago
60 Minute Opening Range Breakout about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Seres Therapeutics, Inc. Description

Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company's product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI to prevent the initial recurrence of CDI; SER-287 to treat inflammatory bowel disease, including ulcerative colitis; and SER-155 to treat enteric pathogens, such as antibiotic-resistant bacteria. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Autoimmune Disease Clinical Development Antibiotics Inflammatory Bowel Disease Ulcerative Colitis Ulcer Colitis Diarrhea Digestive Diseases Antimicrobial Resistance Cdi Clostridioides Difficile Clostridium Difficile Infection Clostridium Difficile

Is MCRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.05
52 Week Low 0.54
Average Volume 4,006,531
200-Day Moving Average 0.93
50-Day Moving Average 0.88
20-Day Moving Average 0.79
10-Day Moving Average 0.77
Average True Range 0.07
RSI (14) 49.75
ADX 14.42
+DI 18.17
-DI 20.30
Chandelier Exit (Long, 3 ATRs) 0.68
Chandelier Exit (Short, 3 ATRs) 0.90
Upper Bollinger Bands 0.88
Lower Bollinger Band 0.70
Percent B (%b) 0.68
BandWidth 23.24
MACD Line -0.03
MACD Signal Line -0.04
MACD Histogram 0.0095
Fundamentals Value
Market Cap 106.24 Million
Num Shares 129 Million
EPS -1.11
Price-to-Earnings (P/E) Ratio -0.74
Price-to-Sales 1.16
Price-to-Book 63.84
PEG Ratio -0.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.88
Resistance 3 (R3) 0.87 0.85 0.87
Resistance 2 (R2) 0.85 0.83 0.85 0.87
Resistance 1 (R1) 0.84 0.83 0.84 0.84 0.86
Pivot Point 0.81 0.81 0.81 0.81 0.81
Support 1 (S1) 0.80 0.80 0.80 0.80 0.78
Support 2 (S2) 0.77 0.79 0.78 0.78
Support 3 (S3) 0.76 0.77 0.78
Support 4 (S4) 0.77